[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-001", "question": "A 32-year-old female is evaluated for palpitations. Labs reveal a TSH of 7.2 mIU/L (High) and Free T4 of 2.9 ng/dL (High). An MRI of the pituitary shows a 5mm hypoenhancing lesion. Sex Hormone Binding Globulin (SHBG) levels are elevated. Which of the following is the most likely diagnosis?", "options": ["Resistance to Thyroid Hormone (RTH) beta", "TSH-secreting pituitary adenoma (TSHoma)", "Graves' disease", "Familial Dysalbuminemic Hyperthyroxinemia", "Heterophile antibody interference"], "answer": "B", "answer_index": 1, "explanation": "Both RTH and TSHoma present with inappropriate TSH secretion (high T4, non-suppressed TSH). The key differentiator is the peripheral tissue response. In TSHoma, peripheral tissues (like the liver) are sensitive to the high thyroid hormone levels, resulting in elevated markers of thyroid action such as Sex Hormone Binding Globulin (SHBG). In RTH, the peripheral tissues are resistant, so SHBG levels are typically normal. The pituitary lesion supports TSHoma, but incidentalomas are common; the metabolic profile (high SHBG) confirms the diagnosis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "topics_mapped", "source_label_raw": "endocrinology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "Let’s break this down:  \n\n- **TSH is high** (7.2 mIU/L) → normally, high TSH means primary hypothyroidism, but here **Free T4 is also high** → inappropriate TSH secretion (not suppressed).  \n- MRI shows a **5 mm hypoenhancing pituitary lesion** → possible microadenoma.  \n- **SHBG is elevated** → thyroid hormone effect on liver (high thyroid hormone levels increase SHBG).  \n\nIn **TSHoma**, TSH is inappropriately normal/high despite high FT4, and SHBG is often elevated due to thyroid hormone excess. Pituitary adenoma fits.  \n\nOther options:  \n- **A. RTH beta** → TSH usually normal/mildly elevated, FT4 high, but SHBG is normal/low (tissue resistance in liver too), and pituitary MRI normal.  \n- **C. Graves’ disease** → TSH suppressed, not elevated.  \n- **D. Familial dysalbuminemic hyperthyroxinemia** → artifact in some FT4 assays, but TSH normal, SHBG normal, no pituitary lesion.  \n- **E. Heterophile antibody interference** → could cause falsely high TSH and/or FT4 in some assays, but SHBG elevation suggests true thyroid hormone excess, and pituitary lesion is incidental/unlikely explained.  \n\nMost consistent is **TSHoma**.  \n\nThe answer is B"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-002", "question": "A 52-year-old male presents with severe chronic watery diarrhea and 15 kg weight loss over 6 months. He has a history of hypertension treated with olmesartan and amlodipine. Celiac serologies (tTG-IgA, EMA) are negative. Upper endoscopy reveals scalloping of duodenal folds; biopsy shows total villous atrophy and increased intraepithelial lymphocytes. HLA-DQ2 and HLA-DQ8 genotyping is negative. A gluten-free diet for 8 weeks yields no clinical improvement. What is the most likely diagnosis?", "options": ["Refractory Celiac Disease Type 1", "Autoimmune Enteropathy", "Olmesartan-associated Enteropathy", "Common Variable Immunodeficiency (CVID)", "Tropical Sprue"], "answer": "C", "answer_index": 2, "explanation": "Olmesartan-associated enteropathy mimics celiac disease histologically (villous atrophy) but occurs in patients without the genetic predisposition for celiac disease (HLA-DQ2/DQ8 negative). The key discriminator is the medication history and lack of response to gluten withdrawal. Refractory celiac disease requires a prior confirmed diagnosis of celiac disease (positive genetics/serology).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "C", "model_outputs": "The patient has villous atrophy with negative celiac serology and HLA-DQ2/DQ8, and no response to a gluten-free diet.  \nThe key clue is the medication history: olmesartan is known to cause a sprue-like enteropathy that mimics celiac disease but is medication-induced.  \nDiscontinuing olmesartan typically leads to improvement, which fits this presentation.  \n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-003", "question": "A 34-year-old male presents with progressive dyspnea. He has a BMI of 17 kg/m2. Chest radiography shows apical pleural thickening. High-resolution CT demonstrates upper-lobe predominant subpleural fibrosis and a flattened chest configuration ('platythorax'). He has no history of asbestos exposure or connective tissue disease. Which of the following is the most likely diagnosis?", "options": ["Idiopathic Pulmonary Fibrosis (IPF)", "Pleuroparenchymal Fibroelastosis (PPFE)", "Chronic Hypersensitivity Pneumonitis", "Lymphangioleiomyomatosis (LAM)", "Pulmonary Alveolar Proteinosis"], "answer": "B", "answer_index": 1, "explanation": "Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural lung parenchyma, predominantly in the upper lobes. The radiographic hallmark is the 'platythorax' (flattening of the chest cage) due to fibrosis progression. This contrasts with IPF (lower lobe predominant) and Hypersensitivity Pneumonitis (mosaic attenuation, centrilobular nodules).", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "The patient’s presentation includes low BMI, apical pleural thickening on imaging, upper-lobe predominant subpleural fibrosis, and platythorax — all characteristic of pleuroparenchymal fibroelastosis (PPFE).  \nPPFE is a rare interstitial lung disease with these typical features and no known cause in the idiopathic form.  \nOther options do not fit:  \n- IPF is lower lobe and basilar predominant.  \n- Chronic hypersensitivity pneumonitis typically shows mid-upper lobe ground-glass and centrilobular nodules.  \n- LAM occurs in women of childbearing age with cysts.  \n- Pulmonary alveolar proteinosis shows “crazy-paving” pattern.  \n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-004", "question": "A patient with severe chronic hyponatremia (Na 105 mEq/L) and concomitant hypokalemia (K 2.5 mEq/L) is admitted. The resident orders 40 mEq of IV KCl to correct the potassium. Two hours later, the serum sodium has risen to 112 mEq/L, exceeding the safe correction limit. What is the primary physiological mechanism for this rapid rise in serum sodium?", "options": ["Osmotic demyelination releasing sodium", "Intracellular sodium shift in exchange for potassium", "Aldosterone suppression", "Volume expansion suppression of ADH", "Renal sodium retention"], "answer": "B", "answer_index": 1, "explanation": "Administered potassium enters cells to replenish intracellular stores; to maintain electroneutrality, sodium exits the cells into the extracellular space. Therefore, potassium administration acts osmotically equivalent to sodium administration in raising serum tonicity. Additionally, correcting hypokalemia may improve renal concentrating ability, but the cation exchange is the immediate cause of the rapid sodium rise.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "abms_specialty": "Nephrology", "abms_source": "topics_mapped", "source_label_raw": "Nephrology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed125.jsonl", "pred": "B", "model_outputs": "In severe chronic hyponatremia with hypokalemia, giving KCl intravenously increases extracellular potassium.  \nPotassium enters cells, and to maintain electroneutrality, sodium shifts out of cells into the extracellular fluid.  \nThis sodium shift can raise serum sodium concentration independent of changes in total body water or sodium.  \n\nThe other options are incorrect:  \n- Osmotic demyelination (A) is a complication, not a cause of sodium rise.  \n- Aldosterone suppression (C) would lower sodium, not raise it rapidly.  \n- ADH suppression (D) or renal sodium retention (E) would not explain a rise within 2 hours after KCl administration.  \n\nThe answer is B"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-005", "question": "A 24-year-old female presents with menorrhagia and prolonged bleeding after a tooth extraction. Coagulation profile shows a prolonged aPTT (55s) and normal PT. Factor VIII activity is 6% (low). von Willebrand Factor (vWF) Antigen is 95% (normal), and vWF Ristocetin Cofactor Activity is 92% (normal). A mixing study corrects the aPTT. Her father has a similar bleeding history, but her brothers are unaffected. What is the most likely diagnosis?", "options": ["Hemophilia A (Carrier state)", "Type 2N von Willebrand Disease", "Type 2A von Willebrand Disease", "Acquired Hemophilia A", "Factor XI Deficiency"], "answer": "B", "answer_index": 1, "explanation": "Type 2N (Normandy) vWD is caused by a defect in the vWF binding domain for Factor VIII, leading to a secondary deficiency of Factor VIII (due to short half-life) despite normal vWF levels and function. It mimics Hemophilia A but exhibits autosomal recessive inheritance (affecting females significantly), whereas Hemophilia A is X-linked. The normal vWF antigen and activity rule out Type 1 and 2A/2B/2M.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "abms_specialty": "Hematology", "abms_source": "target_topic", "source_label_raw": "Hematology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "Let’s break this down:  \n\n- **Prolonged aPTT, normal PT** → suggests an intrinsic pathway factor deficiency (VIII, IX, XI, XII, etc.).  \n- **Low factor VIII activity (6%)** → severe deficiency.  \n- **vWF antigen and Ristocetin cofactor activity normal** → rules out most types of vWD except type 2N (Normandy).  \n- **Type 2N vWD** → mutation in vWF’s factor VIII binding site → decreased survival of factor VIII in plasma → low factor VIII level, but normal vWF antigen and function (except FVIII binding).  \n- **Mixing study corrects** → suggests factor deficiency, not an inhibitor (though acquired hemophilia A also corrects in mixing studies, but here there’s a family history).  \n- **Family history** → father affected (X-linked hemophilia A usually not passed from father to daughter unless mother is carrier; here father affected suggests autosomal inheritance pattern). Type 2N is autosomal recessive (or codominant), so father could pass it, and daughter homozygous/compound heterozygous. Brothers unaffected could fit if they inherited normal allele from mother.  \n- **Hemophilia A carrier** → usually factor VIII around 50% on average, not 6% (unless extreme lyonization). But father having similar bleeding history argues against X-linked carrier (fathers with hemophilia A don’t pass it to daughters except in rare cases with affected father + carrier mother).  \n\nGiven normal vWF:Ag and vWF:RCo, **type 2A** is out (that shows decreased RCo/Ag ratio).  \n**Acquired hemophilia A** usually occurs in older adults, no family history, and mixing study would show *no correction* if inhibitor present, but here it corrects → not acquired.  \n**Factor XI deficiency** → would have low factor XI, not low factor VIII.  \n\nBest match: **Type 2N vWD** → autosomal inheritance, low FVIII, normal vWF levels and function except FVIII binding.  \n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-006", "question": "A 19-year-old male presents with recurrent fevers, livedo reticularis, and two episodes of lacunar ischemic stroke. Laboratory evaluation reveals low serum IgM and IgG levels, mild neutropenia, and elevated inflammatory markers. A biopsy of a skin nodule shows necrotizing vasculitis. Genetic testing is most likely to reveal a loss-of-function mutation in which gene?", "options": ["MEFV", "ADA2", "NOD2", "TNFRSF1A", "STAT3"], "answer": "B", "answer_index": 1, "explanation": "This clinical presentation is classic for Deficiency of Adenosine Deaminase 2 (DADA2). It presents with a polyarteritis nodosa (PAN)-like vasculitis, early-onset strokes, and mild immunodeficiency (hypogammaglobulinemia/cytopenias). It is an autosomal recessive autoinflammatory disease. MEFV causes Familial Mediterranean Fever; STAT3 causes Hyper-IgE syndrome.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "abms_specialty": "Immunology", "abms_source": "target_topic", "source_label_raw": "Immunology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-007", "question": "A 24-year-old male presents with recurrent fevers, livedo racemosa, and acute left hemiparesis. MRI shows a lacunar infarct in the internal capsule. Angiography reveals a 'beads-on-a-string' appearance in the mesenteric and renal arteries. Laboratory evaluation shows low serum IgM and IgG levels. Genetic testing confirms a biallelic loss-of-function mutation in ADA2. Which of the following is the most appropriate maintenance therapy?", "options": ["Cyclophosphamide", "Rituximab", "Etanercept", "Prednisone monotherapy", "Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "The patient has Deficiency of Adenosine Deaminase 2 (DADA2), which mimics Polyarteritis Nodosa (PAN) but is distinct due to its association with early-onset strokes and hypogammaglobulinemia. Unlike classic PAN, which is treated with cyclophosphamide, DADA2 is driven by TNF-alpha dysregulation. TNF inhibitors (like etanercept) are the treatment of choice and are highly effective in preventing recurrent strokes, whereas cyclophosphamide is often ineffective.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Rheumatology/Musculoskeletal", "abms_specialty": "Rheumatology/Musculoskeletal", "abms_source": "topics_mapped", "source_label_raw": "rheumatology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "C", "model_outputs": "The clinical presentation, imaging findings, and genetic testing are consistent with deficiency of adenosine deaminase 2 (DADA2). Anti-TNF therapy, such as etanercept, is the recommended maintenance treatment to control vasculitis and prevent strokes, supported by evidence of its efficacy in this condition.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-008", "question": "A 68-year-old male presents with fever of unknown origin, 15 kg weight loss, and fatigue 4 years after undergoing aortic valve replacement. Labs reveal pancytopenia and elevated liver enzymes. TTE and TEE show no vegetations. PET-CT demonstrates hypermetabolic activity in the spleen and bone marrow. Bone marrow biopsy reveals non-caseating granulomas. Standard blood cultures are negative. Which of the following is the most likely etiology?", "options": ["Sarcoidosis", "Culture-negative endocarditis (HACEK group)", "Mycobacterium chimaera", "Tropheryma whipplei", "Late-onset prosthetic valve thrombosis"], "answer": "C", "answer_index": 2, "explanation": "This is the classic presentation of disseminated *Mycobacterium chimaera* infection associated with contaminated heater-cooler units used during cardiopulmonary bypass. The incubation period can be several years. It presents with systemic symptoms, cytopenias, and granulomatous inflammation (often misdiagnosed as sarcoidosis). Diagnosis requires specific mycobacterial blood cultures or tissue PCR.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "C", "model_outputs": "The history of aortic valve replacement with fever, weight loss, pancytopenia, elevated liver enzymes, PET findings of splenic and bone marrow uptake, bone marrow granulomas, and negative standard blood cultures is classic for **Mycobacterium chimaera** infection.  \nThis is a known complication from contaminated heater-cooler devices used in cardiac surgery, typically presenting months to years after surgery with culture-negative, disseminated infection mimicking sarcoidosis. Sarcoidosis (A) can cause granulomas but would not explain the temporal relationship to valve replacement. HACEK endocarditis (B) is less likely without valvular vegetations on TEE. Whipple’s disease (D) usually causes PAS-positive macrophages, not non-caseating granulomas. Prosthetic valve thrombosis (E) wouldn’t cause this systemic picture.\n\n**The answer is C**"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-009", "question": "A 65-year-old male with metastatic colorectal cancer is being evaluated for third-line therapy. Molecular profiling reveals the tumor is KRAS wild-type, NRAS wild-type, and BRAF V600E mutated. Microsatellite status is stable (MSS). Which of the following regimens is the most appropriate targeted therapy?", "options": ["Vemurafenib monotherapy", "Encorafenib plus Cetuximab", "Dabrafenib plus Trametinib", "Pembrolizumab monotherapy", "Regorafenib monotherapy"], "answer": "B", "answer_index": 1, "explanation": "In BRAF V600E-mutated colorectal cancer, BRAF inhibitor monotherapy (e.g., Vemurafenib) is ineffective due to a feedback loop that causes rapid upregulation of EGFR signaling. The standard of care, based on the BEACON trial, is the combination of a BRAF inhibitor (Encorafenib) and an EGFR inhibitor (Cetuximab) to block this feedback loop. Pembrolizumab is only for MSI-High tumors.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "abms_specialty": "Medical Oncology", "abms_source": "target_topic", "source_label_raw": "Medical Oncology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "For a patient with metastatic colorectal cancer that is KRAS/NRAS wild-type but BRAF V600E mutated and MSS, the standard targeted therapy is a combination of a BRAF inhibitor plus an anti-EGFR antibody.  \n\n- **Vemurafenib monotherapy** (A) is ineffective in colorectal cancer due to feedback reactivation of EGFR signaling.  \n- **Encorafenib plus Cetuximab** (B) is an approved regimen for BRAF V600E–mutated metastatic colorectal cancer (based on the BEACON CRC trial).  \n- **Dabrafenib plus Trametinib** (C) is used in melanoma and non-small cell lung cancer with BRAF V600E, but not standard in colorectal cancer.  \n- **Pembrolizumab monotherapy** (D) is for MSI-H/dMMR tumors, not MSS.  \n- **Regorafenib monotherapy** (E) is a multikinase inhibitor used in later lines regardless of BRAF status, but not the best targeted option for BRAF V600E.  \n\nThe most appropriate targeted therapy here is **Encorafenib plus Cetuximab**.  \n\nThe answer is B"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-010", "question": "A 45-year-old male presents with recurrent episodes of hypotension and syncope occurring 3 to 6 hours after eating dinner. He has no history of atopy. Skin prick tests to beef, pork, and lamb are negative, but intradermal testing is positive. Serum tryptase is normal. Specific IgE testing reveals elevated IgE to galactose-alpha-1,3-galactose. Which of the following is the most likely vector for sensitization in this patient?", "options": ["Ixodes scapularis (Black-legged tick)", "Amblyomma americanum (Lone Star tick)", "Dermacentor variabilis (American Dog tick)", "Aedes aegypti (Mosquito)", "Ctenocephalides felis (Cat flea)"], "answer": "B", "answer_index": 1, "explanation": "This is Alpha-gal syndrome, a delayed anaphylactic reaction to mammalian meat (red meat) mediated by IgE against the alpha-gal carbohydrate. Sensitization is caused by bites from the Lone Star tick (*Amblyomma americanum*) in the US. The reaction is characteristically delayed (3-6 hours) unlike typical protein-based food allergies.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "abms_specialty": "Allergy/Immunology", "abms_source": "target_topic", "source_label_raw": "Allergy/Immunology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "The patient’s presentation—delayed anaphylaxis to red meat, positive intradermal testing, elevated IgE to galactose-alpha-1,3-galactose (alpha-gal)—is classic for alpha-gal syndrome. This condition is strongly associated with sensitization from the bite of the Lone Star tick (Amblyomma americanum), which is known to introduce alpha-gal into the human host.\n\nThe answer is (B)"}]